Loading…
Pulse Biosciences, Inc. is projected to rise to $56.30 by 2027, a +61% move from its current price of $35.04. PLSE is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $33.75 | $35.07 | $36.44 | +0.09% |
| Aug 2 | $33.25 | $35.10 | $37.05 | +0.17% |
| Aug 3 | $32.88 | $35.13 | $37.54 | +0.26% |
| Aug 4 | $32.57 | $35.16 | $37.96 | +0.34% |
| Aug 5 | $32.30 | $35.19 | $38.34 | +0.43% |
| Aug 6 | $32.07 | $35.22 | $38.68 | +0.52% |
| Aug 7 | $31.85 | $35.25 | $39.01 | +0.60% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $31.85 | $35.25 | $39.01 | +0.60% |
| Week 2 | $30.73 | $35.46 | $40.92 | +1.21% |
| Week 3 | $29.93 | $35.68 | $42.52 | +1.81% |
| Week 4 | $29.31 | $35.89 | $43.95 | +2.43% |
| Week 5 | $28.79 | $36.11 | $45.28 | +3.04% |
| Week 6 | $28.34 | $36.32 | $46.55 | +3.66% |
| Week 7 | $27.95 | $36.54 | $47.77 | +4.29% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians.
The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
It is categorized within Healthcare.
Pulse Biosciences, Inc. trades under the symbol PLSE and is a Healthcare stock. It currently trades at $35.47 per share, with a market capitalization of $2.45B and a rank of 1824.
The current price sits amid a forecast that shifts from neutral in 2026 to bullish thereafter, with the 2026 avg price at $35.47 and a 2027 avg of $54.64. The multi-year path shows substantial upside, with 2030 at an avg of $90.37 and a max of $140.03, underscoring meaningful long-term appreciation.
A major floor 46.8% below — a decisive break under it would weaken the trend.
The nearest floor, 27.4% below — buyers have tended to step in here.
Price is pressing into resistance (1.2% away) — a breakout level to watch.
A major ceiling 19.9% above — clearing it would confirm fresh momentum.
Key PLSE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PLSE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $33.56 | Buy | $33.77 | Buy |
| MA 10 | $31.94 | Buy | $32.25 | Buy |
| MA 20 | $29.62 | Buy | $30.43 | Buy |
| MA 50 | $27.38 | Buy | $27.72 | Buy |
| MA 100 | $24.43 | Buy | $25.05 | Buy |
| MA 200 | $20.27 | Buy | $22.11 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 67.61 | Neutral |
| Stoch RSI (14) | 86.44 | Sell |
| CCI (20) | 145.54 | Buy |
| Williams %R (14) | -4.30 | Info |
| MACD (12,26,9) | 0.62 | Buy |
| ROC (12) | 37.63 | Buy |
| Bollinger %B (20,2) | 0.95 | Neutral |
| Stochastic %K (14) | 95.70 | Sell |
| TRIX (15) | 0.73 | Buy |
| Awesome (5,34) | 5.19 | Buy |
| Ultimate (7,14,28) | 70.48 | Sell |
| Momentum (10) | 7.66 | Buy |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 35.52 | Sell |
| ADX (14) | 21.62 | Buy |
| ATR (14) | 1.19 | Info |
The 30-day technical picture is characterized as BULLISH in sentiment. The RSI is 70, suggesting strength near overbought levels. The 50-day simple moving average is $26.71, while the 200-day simple moving average is $19.98.
Key support is at $24.37 and resistance at $32.79, with a 30-day trading range of $27.92 to $45.07.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $13.39 | $35.04 | $49.01 | 0% | Neutral | |
| $43.25 | $56.30 | $78.39 | +61% | Bullish | |
| $52.14 | $70.73 | $103.52 | +102% | Bullish | |
| $59.09 | $82.97 | $126.20 | +137% | Bullish | |
| $66.52 | $96.34 | $151.28 | +175% | Bullish | |
| $61.00 | $90.87 | $146.69 | +159% | Bullish | |
| $71.75 | $109.77 | $181.62 | +213% | Bullish | |
| $97.20 | $152.49 | $257.94 | +335% | Bullish | |
| $105.93 | $170.22 | $293.85 | +386% | Bullish | |
| $118.50 | $194.90 | $342.80 | +456% | Bullish | |
| $180.03 | $329.84 | $627.02 | +841% | Bullish | |
| $261.79 | $581.76 | $1,235.80 | +15.6x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $13.39 | $35.04 | $40.93 | +0.00% |
| August 2026 | $30.10 | $35.63 | $43.38 | +1.68% |
| September 2026 | $31.63 | $37.89 | $46.99 | +6.34% |
| October 2026 | $31.46 | $38.05 | $47.87 | +0.42% |
| November 2026 | $30.30 | $36.93 | $47.01 | -2.94% |
| December 2026 | $31.03 | $38.10 | $49.01 | +3.16% |
Click any year to see its month-by-month PLSE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, PLSE is projected to trade between $13.39 and $49.01, averaging $35.04 — a potential gain of 0% from today's $35.04. A consolidation phase looks the most probable path here.
Pulse Biosciences, Inc.'s 2027 outlook centres on $56.30, within a $43.25 to $78.39 range. That is up +61% on the projected 2026 average. That marks a +61% change versus current levels. Momentum favours further upside here.
By 2028, PLSE could reach as high as $103.52, with a base case around $70.73 and support toward $52.14 — roughly +102% from $35.04. Buyers look set to stay in control over this stretch.
Expect PLSE to range from $59.09 to $126.20 through 2029. The $82.97 average target implies a +137% move from current prices. That is up +17% on the projected 2028 average. Momentum favours further upside here.
The PLSE price prediction for 2030 points to an average of $96.34 (low $66.52, high $151.28) — a potential gain of +175% on today's $35.04. Buyers look set to stay in control over this stretch.
In 2031, PLSE is projected to trade between $61.00 and $146.69, averaging $90.87 — a potential gain of +159% from today's $35.04. That is -6% versus the projected 2030 average. Momentum favours further upside here.
Pulse Biosciences, Inc.'s 2032 outlook centres on $109.77, within a $71.75 to $181.62 range. That is up +21% on the projected 2031 average. That marks a +213% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, PLSE could reach as high as $257.94, with a base case around $152.49 and support toward $97.20 — roughly +335% from $35.04. Momentum favours further upside here.
Expect PLSE to range from $105.93 to $293.85 through 2034. The $170.22 average target implies a +386% move from current prices. That is up +12% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The PLSE price prediction for 2035 points to an average of $194.90 (low $118.50, high $342.80) — a potential gain of +456% on today's $35.04. Momentum favours further upside here.
In 2040, PLSE is projected to trade between $180.03 and $627.02, averaging $329.84 — a potential gain of +841% from today's $35.04. That is up +69% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Pulse Biosciences, Inc.'s 2050 outlook centres on $581.76, within a $261.79 to $1,235.80 range. That is up +76% on the projected 2040 average. That marks a +15.6x change versus current levels. Momentum favours further upside here.
Investing $1,000 in PLSE today (≈ 28.538813 PLSE) could be worth
$16,602.66
+$15,602.66 (+1560%) by 2050 · US Dollar
Based on the average projected PLSE price of $581.76 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PLSEwould be worth at today's price.
$1,000 invested in PLSE on Jul 30, 2025 (≈ 67.888665 PLSE) would be worth
$2,378.82
+$1,378.82 (+137.9%) today · 2.38× · US Dollar
Based on a PLSE entry price of $14.73 vs. today's $35.04.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $31 | $1,130.32 | +13.0% |
| 1 month ago | $27.73 | $1,263.61 | +26.4% |
| 3 months ago | $20.83 | $1,682.19 | +68.2% |
| 6 months ago | $13.83 | $2,533.62 | +153.4% |
| 1 year ago | $14.73 | $2,378.82 | +137.9% |
| All time (5.0y) ago | $20.77 | $1,687.05 | +68.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PLSE forecast.
Our base-case forecast reaches $70.00 around 2028.
Implied market cap at $70.00: $4.84B
The multi-year forecast shows a bullish trajectory from 2027 onward, with rising average prices and high ROI. The 2027 avg is $54.64 with an ROI of 54%, followed by 2028 avg of $68.00 and an ROI of 91.7%, and 2029 avg of $79.09 with an ROI of 123%.
By 2030 the avg is $90.37 with an ROI of 154.8%, and by 2031 the avg is $85.34 with an ROI of 140.6%. The forecast extends to 2040 with an avg of $286.00 and an ROI of 706.3%, and to 2050 with an avg of $498.60 and an ROI of 1305.7%.
These figures are estimates and not guarantees, reflecting potential paths under the given assumptions.
Tap a question to reveal the answer.
2030 forecast shows an avg price of $90.37, a min of $63.22, a max of $140.03, and an ROI of 154.8%, with a BULLISH sentiment.
Forecasts indicate a neutral stance in 2026 (avg $35.47) followed by a bullish trajectory from 2027 onward, with ROIs of 54% in 2027, 91.7% in 2028, 123% in 2029, 154.8% in 2030, 706.3% by 2040, and 1305.7% by 2050.
Yes. The 2030 max is $140.03 and 2031 max is $135.80, with 2032 max $165.82, 2033 max $228.85, 2034 max $259.63, and 2035 max $302.17, so a $100 level is forecast to be reached within the 2030–2032 window.
Sentiment is BULLISH; RSI14 is 70; SMA50 is $26.71; SMA200 is $19.98. Support is $24.37 and resistance is $32.79, with a 30-day range of $27.92 to $45.07.
Current price is $35.47 and market cap is $2.45B, with a market-rank of 1824.
Pulse Biosciences, Inc. Community Discussion
0Share your Pulse Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.